Management of Heart Failure with Reduced Ejection Fraction

Overview

Journal Heart

Date 2022 Aug 16

PMID 35973784

Authors

Paul M Haydock

Andrew S Flett

Affiliations

Soon will be listed here.

Citing Articles

The association of serum hsa-miR-21-5p expression with the severity and prognosis of heart failure with reduced ejection fraction.

Wang L, Guo A, Liang S, Yu L, Shen B, Huang Z BMC Cardiovasc Disord. 2025; 25(1):114.

PMID: 39972425 PMC: 11837298. DOI: 10.1186/s12872-024-04465-y.

Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review.

Lopez-Usina A, Mantilla-Cisneros C, Llerena-Velastegui J J Clin Med Res. 2024; 16(10):449-464.

PMID: 39544327 PMC: 11557505. DOI: 10.14740/jocmr6033.

Cardiac diastolic dysfunction by cigarette smoking is associated with mitochondrial integrity in the heart.

Slotabec L, Wang H, Seale B, Wen C, Filho F, Li J FASEB J. 2024; 38(14):e23826.

PMID: 39046373 PMC: 11323130. DOI: 10.1096/fj.202400858R.

Exploring the mechanism of diabetic cardiomyopathy treated with Qigui Qiangxin mixture based on UPLC-Q/TOF-MS, network pharmacology and experimental validation.

Han Q, Li Y, Yu Y, Yuan H, Wang Z, Guo Y Sci Rep. 2024; 14(1):12119.

PMID: 38802644 PMC: 11130275. DOI: 10.1038/s41598-024-63088-7.

Exploring the Need and Benefits of Digital Therapeutics (DTx) for the Management of Heart Failure in India.

Singh B, Hazra P, Roy S, Garg R, Bhat S, Patki N Cureus. 2024; 15(11):e49628.

PMID: 38161874 PMC: 10755686. DOI: 10.7759/cureus.49628.

References

McIlvennan C, Allen L . Palliative care in patients with heart failure. BMJ. 2016; 353:i1010. DOI: 10.1136/bmj.i1010. View

Halliday B, Wassall R, Lota A, Khalique Z, Gregson J, Newsome S . Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2018; 393(10166):61-73. PMC: 6319251. DOI: 10.1016/S0140-6736(18)32484-X. View

Nieminen M, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola V . EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27(22):2725-36. DOI: 10.1093/eurheartj/ehl193. View

Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316(23):1429-35. DOI: 10.1056/NEJM198706043162301. View

Mullens W, Damman K, Harjola V, Mebazaa A, Brunner-La Rocca H, Martens P . The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(2):137-155. DOI: 10.1002/ejhf.1369. View

Swedberg K, Komajda M, Bohm M, Borer J, Ford I, Dubost-Brama A . Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010; 376(9744):875-85. DOI: 10.1016/S0140-6736(10)61198-1. View

Gulea C, Zakeri R, Alderman V, Morgan A, Ross J, Quint J . Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison. Respir Res. 2021; 22(1):64. PMC: 7903749. DOI: 10.1186/s12931-021-01661-8. View

Zannad F, McMurray J, Krum H, Van Veldhuisen D, Swedberg K, Shi H . Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2010; 364(1):11-21. DOI: 10.1056/NEJMoa1009492. View

10.

. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997; 336(8):525-33. DOI: 10.1056/NEJM199702203360801. View

11.

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36):3599-3726. DOI: 10.1093/eurheartj/ehab368. View

12.

Banner N, Bonser R, Clark A, Clark S, Cowburn P, Gardner R . UK guidelines for referral and assessment of adults for heart transplantation. Heart. 2011; 97(18):1520-7. DOI: 10.1136/heartjnl-2011-300048. View

13.

Abraham W, Adamson P, Bourge R, Aaron M, Costanzo M, Stevenson L . Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011; 377(9766):658-66. DOI: 10.1016/S0140-6736(11)60101-3. View

14.

. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999; 353(9146):9-13. View

15.

Gheorghiade M, Pang P . Acute heart failure syndromes. J Am Coll Cardiol. 2009; 53(7):557-573. DOI: 10.1016/j.jacc.2008.10.041. View

16.

Morton G, Masters J, Cowburn P . Multidisciplinary team approach to heart failure management. Heart. 2017; 104(16):1376-1382. DOI: 10.1136/heartjnl-2016-310598. View

17.

Granger C, McMurray J, Yusuf S, Held P, Michelson E, Olofsson B . Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003; 362(9386):772-6. DOI: 10.1016/S0140-6736(03)14284-5. View

18.

. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet. 1993; 342(8875):821-8. View

19.

Pfeffer M, Braunwald E, Moye L, Basta L, Brown Jr E, Cuddy T . Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327(10):669-77. DOI: 10.1056/NEJM199209033271001. View

20.

Packer M, Bristow M, Cohn J, Colucci W, Fowler M, Gilbert E . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996; 334(21):1349-55. DOI: 10.1056/NEJM199605233342101. View